FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) ... @US

U.S. Food and Drug Administration | FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) ... @US_FDA | Uploaded 2 weeks ago | Updated 1 hour ago
Listen to an audio podcast of the September 12th, 2024 FDA Drug Safety Communication on rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause.

19. mRNA vaccines were developed based on decades of scientific study at NIH...#FDAFacts

MIDD Training Module 4 – Foundation to Model Informed Drug Development and Model Interconnectedness

Regulatory Education for Industry (REdI) Annual Conference 2024: Day 1 – Session 3

Module 6 – Applying MIDD Strategies to Decision-Making

Public Meeting: Optimizing FDA’s Use of and Processes for Advisory Committees (Morning Portion)

Improving the Quality of Life for People with Sickle Cell Disease

Eating Too Much Salt? Ways to Cut Back…Gradually

Module 7 – Case Study 1: Optimizing CERA Pediatric Drug Development

CTP PREXISTING PROGRAM: PART 2 OF 3: PREPARING AND SUBMITTING A STANDALONE PRE-EXISTING SUBMISSION

Seminario web sobre la norma final de FSMA del agua de uso agrícola en la precosecha